Serotonin Uptake InhibitorsFluoxetineCitalopramParoxetineFluvoxamineAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicAntidepressive AgentsSertralineSerotoninSerotonin Plasma Membrane Transport ProteinsCyclohexanolsSerotonin SyndromeDepressive DisorderDepressive Disorder, MajorAdrenergic Uptake InhibitorsReceptor, Serotonin, 5-HT1AReceptors, Serotonin, 5-HT1Receptors, SerotoninLofepramineSerotonin AntagonistsDepressionDothiepinClomipramineDesipramineObsessive-Compulsive DisorderPremenstrual Syndrome1-NaphthylamineSerotonin Receptor AgonistsSerotonin 5-HT1 Receptor AntagonistsReceptor, Serotonin, 5-HT2ASerotonergic NeuronsAnti-Anxiety Agents8-Hydroxy-2-(di-n-propylamino)tetralinToxicity Tests, SubacuteReceptor, Serotonin, 5-HT1BRaphe NucleiNeurotransmitter Uptake InhibitorsSerotonin 5-HT2 Receptor AntagonistsBehavior, AnimalSerotonin 5-HT4 Receptor AgonistsAnxiety DisordersDrug InteractionsSuicideDepressive Disorder, Treatment-ResistantMonoamine Oxidase InhibitorsCognitive TherapyTreatment OutcomeMianserinPsychiatric Status Rating ScalesReceptors, Serotonin, 5-HT2Serotonin AgentsFenfluraminePregnancy ComplicationsDouble-Blind MethodSexual Dysfunction, PhysiologicalAnxietySwimmingTryptophan HydroxylaseNorepinephrine Plasma Membrane Transport ProteinsNortriptylineMoclobemideDroxidopaDose-Response Relationship, DrugPanic DisorderMicrodialysisAmitriptylinePatient Dropouts5,7-DihydroxytryptamineAntipsychotic AgentsRandomized Controlled Trials as TopicPsychotherapyAutoreceptorsPiperazinesPsychotropic DrugsImmobility Response, TonicRats, Sprague-DawleyCytochrome P-450 CYP2D6AlprazolamImipramine5-HydroxytryptophanDrug Utilization ReviewPhenelzineBrainSerotonin 5-HT1 Receptor AgonistsAnalysis of VarianceBupropionHindlimb SuspensionPlacebosEjaculationMotor ActivityDrug CostsTime FactorsThiophenesBenzodiazepinesMaprotilineMembrane Transport ProteinsDrug OverdosePrenatal Exposure Delayed EffectsNorepinephrine